ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
39.72
0.20%
US Tech 100
20,897.20
-1.35%
S&P 500
5,970.84
-1.11%
US Dollar vs CAD
1.44175
-0.01%
Bitcoin
94,953.71
0.84%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Soligenix Inc (SNGX)

  7. Soligenix Inc (SNGX) News

SNGX

Soligenix (SNGX)

Soligenix Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SNGX
DateTimeSourceHeadlineSymbolCompany
12/16/20246:30AMPR Newswire (US)Soligenix Initiates Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
12/13/20244:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20243:26PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20243:25PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20243:24PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20243:23PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20243:22PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/13/20243:20PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SNGXSoligenix Inc
12/02/20246:30AMPR Newswire (US)HyBryte™ Clinical Results Demonstrate Continued Improvement Post-TreatmentNASDAQ:SNGXSoligenix Inc
11/19/20246:30AMPR Newswire (US)Soligenix Announces Formation of European Medical Advisory Board for Cutaneous T-Cell LymphomaNASDAQ:SNGXSoligenix Inc
11/14/20246:15AMPR Newswire (US)Soligenix Initiates a Phase 2 Clinical Trial of SGX945 (dusquetide) for the treatment of Behçet's DiseaseNASDAQ:SNGXSoligenix Inc
11/08/20243:14PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
11/08/20243:12PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
11/08/20243:10PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
11/08/20243:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNGXSoligenix Inc
11/08/20246:30AMPR Newswire (US)Soligenix Announces Recent Accomplishments And Third Quarter 2024 Financial ResultsNASDAQ:SNGXSoligenix Inc
10/24/20246:30AMGlobeNewswire Inc.Soligenix, Inc. to Present at the 2024 ThinkEquity ConferenceNASDAQ:SNGXSoligenix Inc
10/22/20246:30AMPR Newswire (US)Soligenix Receives Hong Kong Patent for Improved Production of Synthetic HypericinNASDAQ:SNGXSoligenix Inc
10/16/20246:30AMPR Newswire (US)Soligenix Invited to Present at Upcoming Investor ConferencesNASDAQ:SNGXSoligenix Inc
10/11/20243:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
10/07/20246:30AMPR Newswire (US)HyBryte™ Expanded Treatment Results to be Presented at the European Organisation for Research and Treatment of Cancer ConferenceNASDAQ:SNGXSoligenix Inc
10/03/20246:30AMPR Newswire (US)Soligenix Announces Partnership with Sterling Pharma SolutionsNASDAQ:SNGXSoligenix Inc
09/16/20246:30AMPR Newswire (US)Join Soligenix's Exclusive Live Investor Webinar and Q&A Session on September 18, 2024NASDAQ:SNGXSoligenix Inc
09/03/20246:30AMPR Newswire (US)Soligenix Receives European Patent for Improved Production of Synthetic HypericinNASDAQ:SNGXSoligenix Inc
08/16/20243:19PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:SNGXSoligenix Inc
08/16/20243:13PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:SNGXSoligenix Inc
08/09/20243:09PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
08/09/20243:07PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SNGXSoligenix Inc
08/09/20243:05PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SNGXSoligenix Inc
 Showing the most relevant articles for your search:NASDAQ:SNGX

Your Recent History

USOTC
WDLF
Decentral Life (PK)
USOTC
BIEL
Bioelectronics (PK)
COIN
XRPUSD
Ripple
USOTC
HMBL
HUMBL (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
NASDAQ
COOP
Mr Cooper
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
CGAC
Code Green Apparel (PK)
USOTC
PHIL
PHI (PK)
USOTC
RNVA
Rennova Health (CE)
USOTC
ELTP
Elite Pharmaceuticals (QB)
USOTC
NBRI
North Bay Resources (PK)
NASDAQ
AVXL
Anavex Life Sciences
USOTC
FNMA
Fannie Mae (QB)
USOTC
RDAR
Raadr (PK)
NASDAQ
LWLG
Lightwave Logic
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads